Investor Stock List
Ranked #2,073 of 8,699 institutional investors

Commodore Capital LP

New York, NY

$1.22B
US stock portfolio at live prices · today −$3.3M (−0.27%)
Market closed. Prices as of Nov 20, 6:11 AM ET
Value at quarter end (Q3 2026)
$1.29B
Change from Q2 2026
−$388.3M (−23.13%)
Positions
27 · 6 new, 4 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$258M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
RLAY 15.7%ELVN 12.5%ANRO 5.93%SYRE 5.61%AMLX 4.30%
StockSharesValue, live% of portfoliovs Q2 2026
RLAY Relay Therapeutics, Inc.12,000,000$191M15.7%Unchanged
ELVN Enliven Therapeutics, Inc.3,275,000$152M12.5%Unchanged
ANRO Alto Neuroscience Inc2,723,196$72.2M5.93%Unchanged
SYRE Spyre Therapeutics, Inc.700,000$68.3M5.61%Reduced −17%
AMLX Amylyx Pharmaceuticals, Inc.2,000,000$52.4M4.30%Reduced −65%
LBRX LB Pharmaceuticals Inc1,282,273$51.3M4.22%Reduced −15%
COGT Cogent Biosciences, Inc.1,265,000$35.1M2.88%Reduced −59%
TYRA Tyra Biosciences, Inc.1,725,000$34.0M2.80%Reduced −8%
KRSA Korsana Biosciences, Inc.877,022$31.1M2.55%New
CLDX Celldex Therapeutics, Inc.1,000,000$28.0M2.30%Reduced −26%
SRZN Surrozen, Inc.885,000$27.1M2.23%New
SGMT Sagimet Biosciences Inc.2,757,742$26.5M2.18%New
KYMR Kymera Therapeutics, Inc.175,000$20.9M1.72%Reduced −30%
DFTX Definium Therapeutics, Inc.700,000$20.6M1.70%Reduced −65%
ATTO Attovia Therapeutics, Inc.1,160,000$18.1M1.48%New
ADRX ADARx Pharmaceuticals, Inc.1,260,577$17.8M1.47%New
PEPG PepGen Inc.4,475,000$17.6M1.44%Unchanged
ANTX AN2 Therapeutics, Inc.2,933,680$15.3M1.26%Unchanged
EDIT Editas Medicine, Inc.8,889,000$15.2M1.25%Unchanged
AGEN Agenus Inc.1,985,387$12.2M1.00%New
IPSC Century Therapeutics, Inc.8,695,652$11.5M0.94%Unchanged
ASMB Assembly Biosciences, Inc.461,922$10.4M0.85%Reduced −67%
SABS SAB Biotherapeutics, Inc.2,870,000$8.4M0.69%Unchanged
RLMD Relmada Therapeutics, Inc.2,350,000$7.3M0.60%Added +65%
IKT Inhibikase Therapeutics, Inc.5,397,488$7.0M0.58%Unchanged
AVTX Avalo Therapeutics, Inc.1,018,319$6.9M0.56%Unchanged
LONA LeonaBio, Inc.464,398$1.1M<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TNGX Tango Therapeutics, Inc.2,250,000$51.1M
CATX Perspective Therapeutics, Inc.6,336,782$5.0M
EYPT EyePoint, Inc.4,600,000$1.2M
VTGN Vistagen Therapeutics, Inc.2,788,620$520K